. 2013 Oct 19;4(2):195–220. doi: 10.1007/s13300-013-0042-y
© The Author(s) 2013
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Fig. 4.
SGLT2 inhibitors in late phase clinical development